Z
Zhou Zhiwen
Researcher at China Pharmaceutical University
Publications - 11
Citations - 105
Zhou Zhiwen is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Antibacterial activity & Derivative (chemistry). The author has an hindex of 6, co-authored 11 publications receiving 94 citations.
Papers
More filters
Journal ArticleDOI
Synthesis and biological evaluation of novel ocotillol-type triterpenoid derivatives as antibacterial agents.
Zhou Zhiwen,Cong Ma,Hengyuan Zhang,Yi Bi,Chen Xia,Hua Tian,Xiaoni Xie,Qing-Guo Meng,Peter J. Lewis,Jinyi Xu +9 more
TL;DR: A novel class of ocotillol-type triterpenoid derivatives have been synthesized and evaluated for their in-vitro antibacterial activity against several representative pathogenic bacterial strains.
Journal ArticleDOI
Novel nitric oxide-releasing isochroman-4-one derivatives: Synthesis and evaluation of antihypertensive activity.
Renren Bai,Xue Yang,Yao Zhu,Zhou Zhiwen,Weijia Xie,Hequan Yao,Jieyun Jiang,Jie Liu,Mingqin Shen,Xiaoming Wu,Jinyi Xu +10 more
TL;DR: Results suggested that NO-donor/natural product hybrids may provide a promising approach for the discovery of novel antihypertensive agents.
Journal ArticleDOI
Novel 3‐Substituted Ocotillol‐Type Triterpenoid Derivatives as Antibacterial Candidates
Yi Bi,Cong Ma,Hengyuan Zhang,Zhou Zhiwen,Yang Jian,Zhang Zhenlei,Qing-Guo Meng,Peter J. Lewis,Jinyi Xu +8 more
TL;DR: Ocotillol‐type triterpenoid derivatives synthesized starting from PPD showed excellent antibacterial activity against several representative bacteria, and chloramphenicol turned from a bacteriostatic to a bactericidal agent when combined with compound 11 against B. subtilis 168.
Journal ArticleDOI
Design, Synthesis and Antibacterial Evaluation of 3-Substituted Ocotillol-Type Derivatives
TL;DR: Novel serious C-3 substituted ocotillol-type derivatives 7–26 were designed and synthesized, and compound 22 exhibited excellent antibacterial activity with minimum inhibitory concentrations (MIC) values of 2 μg/ mL against MRSA USA300 and 4 μg/mL against B. subtilis.